发明名称 TREATMENT OF MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS
摘要 The present disclosure provides novel compositions and methods for treating an infection by Middle East respiratory syndrome coronavirus (MERS-CoV). In particular, the present disclosure provides methods that entail administering agents having an anchoring domain that anchors the compound to the surface of a target cell, and a sialidase domain that can act extracellularly to inhibit infection of a target cell by MERS:CoV.
申请公布号 US2017119859(A1) 申请公布日期 2017.05.04
申请号 US201515314782 申请日期 2015.05.29
申请人 Ansun Biopharma, Inc. 发明人 MOSS Ronald D.
分类号 A61K38/47;C07K14/485;C12N9/24;A61K9/00 主分类号 A61K38/47
代理机构 代理人
主权项 1. A method of treating an infection by MERS-CoV in a patient, the method comprising administering to the patient an effective amount of an agent having sialidase activity.
地址 San Diego CA US